David Bracciano, DO
MOHS-Micrographic Surgery · University Park, FLNPI 1013970870
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,414 of the $14,604 with a category attached, or 71.3%. AbbVie accounts for 80.5% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $3,734, more than ten times the $335 reported in 2019.
Across 244 payments — averaging $59.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Sun Pharmaceutical Industries Inc.$461
- Johnson & Johnson$334
- UCB, Inc.$269
- Biofrontera Inc.$228
- Regeneron Healthcare Solutions, Inc.$218
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$10,41471%
- Food & beverage$3,63525%
- Education$5554%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 151 | $11,760 |
| Sun Pharmaceutical Industries Inc. | 8 | $461 |
| Johnson & Johnson | 9 | $334 |
| UCB, Inc. | 6 | $269 |
| Biofrontera Inc. | 3 | $228 |
| Regeneron Healthcare Solutions, Inc. | 5 | $218 |
| Galderma Laboratories, L.p. | 18 | $200 |
| Organon | 4 | $126 |
| Aclaris Therapeutics, Inc. | 1 | $123 |
| Lilly USA, LLC | 4 | $118 |
| Novartis | 5 | $114 |
| Pfizer | 4 | $78 |
| Boehringer Ingelheim | 3 | $74 |
| Incyte Corporation | 4 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Dermavant Sciences, Inc. | 4 | $62 |
| LEO Pharma Inc. | 2 | $57 |
| EPI Health, LLC | 2 | $34 |
| Organogenesis Inc. | 1 | $31 |
| Botanix SB Inc | 1 | $28 |
| Encore Dermatology Inc. | 2 | $24 |
| Almirall LLC | 1 | $23 |
| Sanofi | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Amgen | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,604 in reported general payments places this provider in the 85th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 33 | $149,163 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $87,481 |
| Triamcinolone Acetonide | 432 | $6,188 |
| Ketoconazole | 384 | $5,976 |
| Clobetasol Propionate | 97 | $4,784 |
| Fluocinonide | 96 | $3,222 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 123 | $2,996 |
| Doxycycline Hyclate | 195 | $2,757 |
| Metronidazole | 53 | $2,746 |
| Tretinoin | 11 | $1,271 |
| Clindamycin Phosphate | 33 | $682 |
| Cephalexin | 50 | $568 |
| Gentamicin Sulfate | 20 | $500 |
| Famciclovir | 12 | $483 |
| Mupirocin | 74 | $434 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in University Park
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.